Thread: SLV 308 in People with Advanced Parkinson’s Disease Experiencing Motor Disturbances
View Single Post
Old 07-23-2007, 05:37 AM
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
  
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default SLV 308 in People with Advanced Parkinson’s Disease Experiencing Motor Disturbances
SLV 308 in People with Advanced Parkinson’s Disease Experiencing Motor Disturbances

Official Study Title: The Mondrian Study: A multicenter, randomized, double-blind, placebo-controlled, parallel group study of SLV 308 as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations

Sponsor: Solvay Pharmaceuticals, Inc.
Clinicaltrials.gov ID : NCT00406588
Study ID : SLV 308.3.002
Last Updated Date: 25 Jun 2007

Symptoms
  • General PD symptoms
  • Loss of Motor Skills

Summary

This is a study of 12 weeks treatment with SLV 308 as an adjunctive treatment (treatment in addition to levodopa) for participants with advanced Parkinson’s disease (PD). The study is planned for 85 centers in 13 countries and is intended to enroll 280 participants globally, 90 of which will be in the U.S. An extension to this study is planned as a separate trial for those participants who are willing and eligible to participate.

READ MORE at PDTrials.org
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall

I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller
Stitcher is offline   Reply With QuoteReply With Quote